CPT for Offenders With SUD

This study has been completed.
Sponsor:
Collaborators:
University of California, Los Angeles
Temple University
University of Kentucky
University of Miami
Information provided by (Responsible Party):
National Development and Research Institutes, Inc.
ClinicalTrials.gov Identifier:
NCT01277939
First received: January 12, 2011
Last updated: August 29, 2013
Last verified: August 2013
  Purpose

This study will evaluate the comparative effectiveness of Therapeutic Education System (TES), a computer-based, psychosocial treatment program, relative to standard care when offered to individuals with substance use disorders in prison settings. The study will assess the comparative effectiveness of these interventions primarily by examining changes in: (1) substance use (e.g., weeks of abstinence), (2) HIV risk behavior (evaluated as both sex-related and drug-related HIV risk behavior) and (3) reincarceration rates. The study will also examine the extent to which these interventions improve psychosocial functioning (e.g., employment, health, and psychological status) and quality of life, and promote relevant skills acquisition (e.g., improve communication skills, reduce "criminal thinking"). The investigators predict significantly better outcomes for E vs. C due to TES' research-based content and use of proven informational technologies.


Condition Intervention
Computer-assisted, Evidence-based Psychosocial Intervention
for Substance Abuse Treatment
Behavioral: Therapeutic Education System (TES)
Behavioral: Standard Care

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Computerized Psychosocial Treatment for Offenders With Substance Use Disorders

Resource links provided by NLM:


Further study details as provided by National Development and Research Institutes, Inc.:

Primary Outcome Measures:
  • Time Line Follow Back for Drug and Alcohol Use (Sobell et al., 1996) [ Time Frame: 6 months post-prison release ] [ Designated as safety issue: No ]
    Measure for substance use.

  • Urinalysis [ Time Frame: 6 months post-prison release ] [ Designated as safety issue: No ]
    To detect any change in illicit drug use.

  • Risk Behavior Survey (Booth et al., 1993) [ Time Frame: 6 months post-prison release ] [ Designated as safety issue: No ]
    To assess both drug-related and sex-related HIV risk behavior.

  • DOC record systems [ Time Frame: At an average of 11 months post-prison release ] [ Designated as safety issue: No ]
    To provide the reincarceration status of each participant.


Secondary Outcome Measures:
  • Coping Strategies Scale [ Time Frame: 6 months post-prison release ] [ Designated as safety issue: No ]
    Measures skills acquisition, such as problem solving and dealing with urges to use substances of abuse (Litt et al., 2005), and psychosocial functioning

  • Addiction Severity Index-Lite [ Time Frame: 6 months post-prison release ] [ Designated as safety issue: No ]
    Measures areas of health status improvement, psychological status, family/social relationships, and employment. (www.tresearch.org)

  • The Treatment Services Review instrument (McLellan et al., www.tresearch.org) [ Time Frame: 6 months post-prison release ] [ Designated as safety issue: No ]
    Used to investigate the role of treatment services received post-release (in aftercare).

  • Brief Drug Abuse Treatment Cost Analysis Program (BriefDATCAP) [ Time Frame: 6 months post-prison release ] [ Designated as safety issue: No ]
    Measures for the cost effectiveness analyses.

  • EuroQol EQ5D (QOL) (the EuroQol Group, 1990) [ Time Frame: 6 months post-prison release ] [ Designated as safety issue: No ]
    Describes and value health-related quality of life and for constructing Quality-Adjusted Life Year estimates (QALYs).


Enrollment: 376
Study Start Date: September 2009
Study Completion Date: August 2012
Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Therapeutic Education System (TES)
Experimental (E) condition, the Therapeutic Education System (TES) delivered via effective informational technologies and multimedia learning tools.
Behavioral: Therapeutic Education System (TES)
Therapeutic Education System (TES) is an interactive, computer-based, psychosocial treatment program. TES is theoretically grounded in evidence-based psychosocial treatments (Community Reinforcement Approach and Cognitive Behavioral Therapy).
Active Comparator: Standard Care
The Control (C) condition, Standard Care, consisting of psycho-educational and psycho-social approaches to substance use disorders (commonly offered in prison settings) delivered by counselors in group formats.
Behavioral: Standard Care
Psycho-educational and psycho-social approaches to substance use disorders (commonly offered in prison settings) delivered by counselors in group formats.

Detailed Description:

The majority of individuals in criminal justice settings across the U.S. have a critical need for science-based, psychosocial treatment that targets substance use and HIV risk behavior. The investigative team has developed and demonstrated the efficacy of an interactive, computer-based, psychosocial treatment pro-gram, the Therapeutic Education System (TES), which can answer this need. TES is theoretically grounded in evidence-based psychosocial treatments (Community Reinforcement Approach and Cognitive Behavioral Therapy), and employs state-of-the-art, proven informational technologies and multimedia learning tools to promote skills acquisition, experiential learning and behavioral change. This computer-based therapeutic tool allows complex interventions to be delivered with fidelity to the evidence-based model and at low cost due to its self-directed nature (e.g., minimal staff time/training needed), thus offering considerable potential for future sustainability and dissemination within criminal justice systems.

The study employs random assignment of incarcerated male and female offenders with substance use disorders (N=526) to either (1) TES (N=263), or (2) Standard Care (N=263), in a multi-site trial conducted in 8 prison substance abuse programs. Along with NDRI (the applicant organization), the collaborating study sites (University of California Los Angeles, Temple University, and the University of Kentucky) operate Research Centers that belong to the Criminal Justice Drug Abuse Treatment Studies (CJDATS) network, a NIDA-funded cooperative agreement, which has established relationships with criminal justice partners from Departments of Corrections across the U.S. Aim 1 is to test the comparative effectiveness of TES vs. Standard Care on measures of drug use (e.g., weeks of abstinence) and HIV risk behavior (both sex-related and drug-related HIV risk behavior) at 3- and 6-months post prison discharge, as well as on reincarceration rates using official Department of Corrections records. Aim 2 is to evaluate the cost and cost-effectiveness of TES relative to standard care. The investigators predict that TES will be significantly more effective and cost effective than Standard Care.

The project is significant in its use of an innovative, computer-based technology and in its potential to produce a major increase in the effective and cost-effective delivery of science-based psychosocial treatment to substance-abusing offenders in prison, and thereby make a considerable public health contribution. Thus, funding the proposed 2-year project can markedly accelerate the pace and achievement of research and dissemination efforts to meet the needs of the U.S. correctional community by providing effective and practical treatment interventions for its large substance-abusing population.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • individual's parole eligibility date or mandatory release date must be scheduled to occur within a minimum of 4 months (to allow intake an treatment to be completed) and a maximum of 6 months (to ensure that their release follows completion of their treatment such that sufficient time remains for post-prison follow-up interviews to occur within the two-year project timeframe)
  • the state criminal justice system must have identified the individual to have a substance use disorder that requires a substance abuse intervention
  • the individual must give their informed consent

Exclusion Criteria:

  • the individual must not already be participating in substance abuse treatment
  • the individual must speak English, as TES is now only available in English
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01277939

Locations
United States, Colorado
Fremont Correctional Facility
Canon City, Colorado, United States, 81215
Four Mile Correctional Center
Canon City, Colorado, United States, 81215
Colorado Territorial Correctional Facility
Canon City, Colorado, United States, 81215
Denver Women's Correctional Facility
Denver, Colorado, United States, 80239
Trinidad Correctional Facility
Model, Colorado, United States, 81509
La Vista Correctional Facility
Pueblo, Colorado, United States, 81002
Sterling Correctional Facility
Sterling, Colorado, United States, 80751
United States, Kentucky
Blackburn Correctional Complex
Lexington, Kentucky, United States, 40511
United States, Pennsylvania
SCI Cambridge Springs
Cambridge Springs, Pennsylvania, United States, 16403
United States, Washington
Airway Heights Corrections Center
Airway Heights, Washington, United States, 99001
Sponsors and Collaborators
National Development and Research Institutes, Inc.
University of California, Los Angeles
Temple University
University of Kentucky
University of Miami
Investigators
Principal Investigator: Stan Sacks, PhD National Development & Research Institutes
  More Information

No publications provided

Responsible Party: National Development and Research Institutes, Inc.
ClinicalTrials.gov Identifier: NCT01277939     History of Changes
Other Study ID Numbers: NDRI-612, 1RC2DA028967
Study First Received: January 12, 2011
Last Updated: August 29, 2013
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on August 20, 2014